Buy Gsk Shares -

: The current forward dividend yield is approximately 3.2% to 3.6% .

: 2025 revenue hit £32.7bn (up 7%), driven by high-margin specialty medicines like HIV and Respiratory treatments. buy gsk shares

: Major product approvals are expected in 2026 for Bepirovirsen (Chronic Hepatitis B) and Tebipenem (UTIs). : The current forward dividend yield is approximately 3

Are you considering GSK primarily for its or for long-term growth in its oncology pipeline? Are you considering GSK primarily for its or

: Despite the recent price rally, GSK still trades at a modest price-to-earnings (P/E) ratio of roughly 14–15x , which some analysts consider undervalued compared to global peers. Income Potential: Dividends

: While long-term momentum is high, short-term technical indicators show a recent consolidation phase , with some analysts suggesting the stock is a "hold" or "reduce" candidate at current levels after hitting recent peaks.

AI responses may include mistakes. For financial advice, consult a professional. Learn more Why is everyone buying GSK shares? | The Motley Fool UK